Nurse Resources

As a primary point of contact for patients, the role of the nurse is pivotal to the continuum of care. While this can be true for any patient, it is especially true for hematology patients undergoing immunotherapy.

In supporting the patient or caregiver, the nurse will assist countless times throughout the course of the patient journey. This assistance can take many forms, including discussions on disease-management options, consent, treatment, identification and monitoring of adverse events, and coordination of the multidisciplinary team. Because treatments are often administered in regional specialized centers, isolation and anxiety can add to an already uncertain future caused by a poor prognosis: The nurse becomes the patient's compass and ensures a comprehensive approach to a complex situation.

By giving more nurses greater access to the specialized immunotherapy knowledge and skills needed to actively role manage their patients, and by creating an online environment that nurtures a transparent exchange of ideas, information, and intelligence, we are helping more nurses to make a difference. We believe medical education should be for everyone. 

American Nurse

Introduction to immunotherapy: What nurses need to know about emerging therapies

  Mar 18 2021 Tagged Nurses, CAR-T, ICI

Understanding these rapidly evolving treatments will help you advocate for patients and manage side effects.

Visit website
Immunotherapy Web Featured Images 3

Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administrat...

The purpose of this paper is to discuss practical considerations for safe blinatumomab delivery from the pharmacy and nursing perspectives.

Visit website
Immunotherapy Web Featured Images 122

CAR T-Cell Therapy Is Active, Safe in ALL

  Mar 09 2021 Tagged CAR-T, MM

Since the publication of the pivotal ELIANA trial in pediatric patients with acute lymphoblastic leukemia, the field of CAR T-cell therapy has grown significantly and left providers better equipped to understand and manage treatment-related adverse effects, such as cytokine release syndrome.

Visit website

Oncology Nursing News: CAR T-Cell Therapy Is Promising in Myeloma

Autologous and allogeneic BCMA-directed CAR T-cell therapies are leading to deep and durable responses in patients with heavily pretreated multiple myeloma, with a low incidence of severe cytokine release syndrome (CRS) and neurotoxicity, explained Yi Lin, MD, PhD, who added that with a pending biologics license application (BLA), the field should start to consider which patients, who don’t fit the typical clinical trial eligibility criteria, might be a candidate for the treatment in real-world practice.

Visit website
Immunotherapy Web Featured Images 113

Episode 139: How CAR and Other T Cells Are Revolutionizing Cancer Treatmen‪t‬

  Feb 24 2021 Tagged CAR-T, Nurses

ONS member Cecily Snyder, BSN, RN, OCN®, BMTCN®, transplant case manager of the blood and marrow transplantation program at Nebraska Medicine in Omaha and member of the Metro Omaha ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss T-cell therapy and how it’s changed approaches to cancer treatment and patient management for oncology nurses.

Visit website
Immunotherapy Web Featured Images 108

The Post-EBMT/CAR-T Nursing Session from VJHemOnc

  Feb 17 2021 Tagged CAR-T, Nurses

With leading experts, Erik Aerts, John Murray, Michelle Kenyon & Rose Ellard. Register now and learn more about key updates in oncology nursing from the recent EBMT/CAR-T meeting. Topics discussed include: Highlights from EBMT/CAR-T, establishing a multidisciplinary CAR-T communication board, immune cell therapies in solid tumors, treatment settings, how to support multidisciplinary teams, palliative care - when to introduce?, future of CAR-T therapies.

Visit website
Immunotherapy Web Featured Images 41

The role of the coordinator nurse in the CAR-T treatment

In this video, Marlene Vercasson, from the Lyon Hospital, shares her experience in the local CAR-T program and Juliet international clinical trial. She reviews the many tasks appointed to the coordinator nurse, in adapting care to the individual patient and making contacts with the Apheresis department, Tissue and Cells Bank, Hematology...

Read more
Immunotherapy Web Featured Images 51

Do mAbs and paraprotein affect COVID-19 Serological Testing in Patients with Mul...

  Dec 04 2020 Tagged mAbs, MM, COVID-19

SARS-CoV-2 (COVID-19) serology tests do not appear to interfere or cause cross-reactivity with therapeutic monoclonal antibody (t-mAb) treatments for hematologic malignancies (HM) such as multiple myeloma (MM), according to a study published in Diagnostics.

Read more
Immunotherapy Web Featured Images 36

CAR T-Cell Therapy Improves Blood Cancer, But Toxicities Are Still Concerning

  Nov 29 2020 Tagged CAR-T, Nurses

In an interview with OncLive, during the 2020 Institutional Perspectives in Cancer webinar on Leukemia and Lymphoma, Olalekan O. Oluwole, MBBS, MD, who is an assistant professor of medicine, hematology, and oncology at Vanderbilt-Ingram Cancer Center, highlighted the evolution of CAR T-cell therapy in leukemia and lymphoma, targets under investigation, and next steps for exploration.

Visit website

Promising Response Rates Build Excitement for CAR T-Cell Therapy in Myeloma

  Oct 31 2020 Tagged Nurses, CAR-T, MM

Anwer, an oncologist, physician-scientist, and stem cell transplant staff physician at the Taussig Cancer Center of Cleveland Clinic, discussed the growing role of CAR T-cell therapy in multiple myeloma and areas of unmet need. 

Visit website